Why Bangladesh has lost 1,000 lives to measles despite record vaccine drive
Bangladesh is grappling with a severe measles epidemic, resulting in over 1,000 deaths since March 2026, despite an emergency campaign that administered nearly 20 million vaccine doses.
Intelligence analysis by Gemini 2.5 Flash
The current measles epidemic in Bangladesh highlights critical public health challenges, including underestimated vaccination targets, significant coverage gaps in routine immunization, and disruptions caused by political upheaval and the COVID-19 pandemic, leading to a high death toll despite extensive vaccination efforts.
Imagine measles is like a super-fast game of tag, and if you don't have your special shield (a vaccine), you can get caught easily. Bangladesh has given out millions of shields, but over 1,000 kids still got sick and couldn't recover. This happened because not enough kids got their shields on time, especially after the country had some big changes in government and other sicknesses like COVID-19 made it hard to get everyone protected.
Analysis
Bangladesh is currently facing a devastating measles epidemic, with over 1,000 reported deaths since March 15, 2026. This alarming figure stands in stark contrast to the previous year, 2025, which recorded only 132 measles cases and zero deaths. The crisis has unfolded despite an emergency vaccination campaign that has administered nearly 20 million doses, exceeding its initial target of 18 million children. This paradox reveals deeper systemic issues within the country's public health infrastructure and planning.
1,009 Deaths
The official data by September 9, 2026, indicated 1,009 deaths attributed to measles, comprising 100 laboratory-confirmed cases and 909 suspected measles deaths. This high mortality rate, particularly among children, points to the severity of the outbreak and the vulnerability of the population. The case of one-year-old Saif Hasan, who died shortly after receiving his first vaccine dose while battling a pre-existing respiratory illness, illustrates how measles can exacerbate underlying conditions, leading to fatal outcomes. The rapid escalation of cases, from a mere 132 in the entirety of 2025 to a nationwide outbreak affecting 58 of 64 districts by mid-April 2026, underscores the rapid spread of this highly contagious disease.
COVID-19 Pandemic
Bangladesh's vulnerability to the current measles epidemic was not sudden but rather a culmination of several years of declining immunization coverage. The 2023 Coverage Evaluation Survey revealed a drop in first-dose measles-rubella coverage from 88.6 percent in 2019 to 86 percent in 2023, with second-dose coverage falling even more significantly from 89 percent to 80.7 percent. This decline was largely exacerbated by disruptions to routine immunization programs during the COVID-19 pandemic. UNICEF also identified misinformation and vaccine hesitancy as contributing factors, leading to a growing pool of susceptible children. The absence of a nationwide supplementary measles-rubella campaign since early 2021 further allowed immunity gaps to widen, falling below the critical 95 percent coverage needed to interrupt transmission.
Sheikh Hasina
The political upheaval following the July 2024 uprising, which led to the ousting of then-Prime Minister Sheikh Hasina, significantly worsened the situation. This change in government resulted in substantial delays in vaccine procurement, as noted by Mushtuq Hussain, a former principal scientific officer at Bangladesh’s Institute of Epidemiology, Disease Control and Research (IEDCR). These delays subsequently caused vaccine shortages throughout 2024 and 2025, directly contributing to the surge in measles cases that began in January 2026. Furthermore, the initial vaccination target of 18 million children for the emergency campaign was found to be an underestimate, as a concurrent Vitamin A supplement campaign targeted 24 million children in the same age group. This discrepancy highlights a fundamental flaw in population estimates, allowing susceptible children to remain unvaccinated despite seemingly high national coverage figures.
Key points
- Over 1,000 people have died from measles in Bangladesh since March 15, 2026, a sharp increase from zero deaths in 2025.
- An emergency vaccination campaign administered nearly 20 million doses, exceeding its initial target of 18 million children.
- Declining routine immunization coverage, from 88.6% in 2019 to 86% in 2023 for the first dose, created a susceptible population.
- Disruptions during the COVID-19 pandemic and political upheaval in July 2024 led to vaccine procurement delays and shortages.
- Public health experts indicate that initial vaccination targets underestimated the actual number of eligible children, masking persistent immunity gaps.
Despite the current challenges, the emergency vaccination campaign has demonstrated Bangladesh's capacity to mobilize and administer nearly 20 million doses. If authorities can accurately reassess population targets, address coverage gaps in hard-to-reach communities, and ensure consistent vaccine procurement, the epidemic could be effectively contained, preventing further loss of life.
The ongoing struggle against measles, despite extensive vaccination efforts, suggests that fundamental issues like inaccurate population estimates and persistent coverage inequities could prolong the epidemic. Future political instability or continued disruptions to routine immunization programs risk further outbreaks and preventable deaths, undermining public health gains.
